The cytoprotective and antiapoptotic activities of overexpressed GRP78 appear to potentiate the radioresistance of hypoxia-adapted cancer cells, so that the artificial downregulation of GRP78 should be considered as a potential way to radiosensitize hypoxic tumors. This evidence concerns the gene HSPA5 and cancer.